Read More

FY24 Election Is A Major Game Changer For US Renewable Sector: Piper Analyst

Piper Sandler analyst Kashy Harrison revised the rating on several Renewables & Alternative Energy companies. The analyst sees benefits accruing to the installers initially (FY24) and inverters eventually (FY25), with the rest of the stock in the coverage benefiting in the long term.

ARRY

Read More

Declining Interest Rates Should Boost Investment Appeal For Canadian Banks: BofA Analyst

B Of A Securities analyst Ebrahim H. Poonawala revised the rating on several Canadian Banks amid a declining rates scenario. The analyst says the rapid decline in interest rates (5yr yield -120bp since Oct high) lowers the probability of tail risk events posed by a higher for longer scenario. 

BMO

Read More

Cancer Player Aadi Bioscience Downgraded: Analyst Highlights ‘Worse Than Expected’ Response Rates

Friday, Aadi Bioscience Inc (NASDAQ: AADI) released results from a planned interim analysis on the first third of participants in the ongoing tumor-agnostic PRECISION1 trial of nab-sirolimus in patients with 

AADI